4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-24-000064
EVP Strategy and Corporate Dev sold 1,990 shares at $137.81 ($274,242)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dolan Matthew Vincent EVP Strategy and Corporate Dev | 2024-04-15 | Sale 10b5-1 | −1,990 | $137.81 | $274,242 | 42,377 | D: show line 1 in the form |
| Open-market sales · 1,990 sh · avg $137.81 · $274,242 | |||||||
Loading xslF345X05/edgardoc.xml…